Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks ' Gestation

Conditions: Gestational Diabetes Interventions: Drug: 500 mg of ursodeoxycholic acid (UDCA); Other: 500 mg of Placebo Sponsors: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials